New triple inhaler aims to tame tough asthma in everyday use
Disease control
Recruiting now
This study looks at how well a once-daily triple inhaler (Trimbow) works for adults with uncontrolled asthma in everyday settings. About 200 people will use the inhaler for 6 months, and researchers will track changes in asthma control and medication adherence. The goal is to see…
Sponsor: Chiesi Slovenija, d.o.o. • Aim: Disease control
Last updated May 15, 2026 11:55 UTC